Bosh sahifaEMCURE • NSE
add
Emcure Pharmaceuticals Ltd
Yopilish kursi
1 279,80 ₹
Kunlik diapazon
1 250,00 ₹ - 1 282,00 ₹
Yillik diapazon
889,00 ₹ - 1 580,00 ₹
Bozor kapitalizatsiyasi
239,16 mlrd INR
Oʻrtacha hajm
221,79 ming
Narx/foyda
34,64
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 21,16 mlrd | 19,47% |
Joriy xarajat | 9,31 mlrd | 5,85% |
Sof foyda | 1,89 mlrd | 64,07% |
Sof foyda marjasi | 8,93 | 37,38% |
Har bir ulushga tushum | 10,38 | — |
EBITDA | 3,89 mlrd | 35,78% |
Amaldagi soliq stavkasi | 24,32% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,41 mlrd | -48,50% |
Jami aktivlari | 82,33 mlrd | 5,46% |
Jami passivlari | 35,91 mlrd | -23,34% |
Umumiy kapital | 46,42 mlrd | — |
Tarqatilgan aksiyalar | 189,53 mln | — |
Narxi/balansdagi bahosi | 5,46 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 13,14% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,89 mlrd | 64,07% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Tashkil etilgan
16-apr, 1981
Sayt
Xodimlar soni
11 146
